Steffie M B Peters

8PUBLICATIONS
14CO-AUTHORS
Medical infection agents (incl. prions)Radiation therapyInstruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 21, 2024
Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.

Bastiaan M Privé, Bas Israël, Marcel J R Janssen

|Apr 03, 2024
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.

Dagmar Grob, Bastiaan M Privé, Constantijn H J Muselaers

|Jul 08, 2023
Urinary excretion kinetics of [177Lu]Lu-PSMA-617.

Maarten de Bakker, Noa Dominicus, Antoi Meeuwis

|Jan 24, 2023
Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.

Steffie M B Peters, Maaike C T Mink, Bastiaan M Privé

|Jul 04, 2021
Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome.

Steffie M B Peters, Bastiaan M Privé, Maarten de Bakker

|Apr 22, 2021
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study.

Bastiaan M Privé, Steffie M B Peters, Constantijn H J Muselaers

Pageof 2